Pamukcuoglu, M., Baysal, N.A. and Pepeler, M.S. (2021) “The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio”, The European Research Journal, 7(6), pp. 541–549. doi:10.18621/eurj.855510.